DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Betamethasone dipropionate; calcipotrieneis the generic ingredient in five branded drugs marketed by Leo Pharma As, MC2, Perrigo Uk Finco, Tolmar, and Taro Pharms, and is included in nine NDAs. There are nine patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Betamethasone dipropionate; calcipotriene has fifty-five patent family members in twenty-nine countries.
There are sixty-six drug master file entries for betamethasone dipropionate; calcipotriene. Seven suppliers are listed for this compound.
Recent Clinical Trials for betamethasone dipropionate; calcipotriene
Identify potential brand extensions & 505(b)(2) entrants
|University of Alabama at Birmingham||Phase 4|
|Eli Lilly and Company||Phase 4|
|Celgene Corporation||Phase 4|